SCHEMBL17613247

SCHEMBL17613247

CCc1nnc(N2CCN(N)CC2)o1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17613248 0.76 RIPK1 (0.39) —
SCHEMBL8388694 0.66 — —
SCHEMBL4607927 0.65 MAPT (0.36) LMNAL3MBTL1
SCHEMBL18901147 0.61 — —
SCHEMBL11919177 0.59 KMT2A (0.39) LMNA
SCHEMBL762438 0.58 — —
SCHEMBL2208379 0.58 HPGD (0.39) LMNAL3MBTL1
SCHEMBL1785878 0.58 POLB (0.36) —
SCHEMBL12049735 0.57 L3MBTL1 (0.41) L3MBTL1
SCHEMBL13285783 0.56 RIPK1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788333-B1 1,2,4-TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INT (DE) 2016-03-23 — — EP disclosed
Send feedback